TruScreen shares gain as quarterly sales double

TruScreen shares gain as quarterly sales double
There's been rapid growth in demand for TruScreen’s technology. (Image: TruScreen)
Staff reporters
Cervical cancer-screening company TruScreen doubled its product sales in the June quarter from a year earlier and lifted unit sales by 73% as Chinese demand started returning to pre-covid levels. The company’s share price rose 0.2 of a cent, or 8%, to 2.7 cents in early trading on the New Zealand stock exchange, taking some of the sting out of its extended slump. The company said recent endorsements of TruScreen’s artificial intelligence-enabled technology supported demand in the June quarter of the March 2024 financial ye...